Stockscreener 앱 받기
158.74
4.36%
-7.24
시장 영업 전:
160.00
1.26
+0.79%
Charles River Laboratories International Inc 주식(CRL)의 최신 뉴스
Halper Sadeh LLC Encourages Charles River Laboratories - GlobeNewswire
Madison Asset Management LLC Purchases Shares of 12,366 Charles River Laboratories International, Inc. $CRL - MarketBeat
Charles River Laboratories International Inc (CRL) Trading Down 8.73% on Feb 11 - GuruFocus
How Does Charles River Laboratories International Stock Compare With Peers? - Trefis
Synthace collaborates with Charles River to offer the global pharma industry more robust, faster and cost-effective assays - MSN
With Charles River Laboratories International Stock Sliding, Have You Assessed The Risk? - Trefis
Earnings Beat: Will Charles River Laboratories International Inc benefit from green energy policiesCEO Change & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Charles River Laboratories International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Analysts Estimate Charles River Laboratories (CRL) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Versor Investments LP Invests $921,000 in Charles River Laboratories International, Inc. $CRL - MarketBeat
Thrivent Financial for Lutherans Has $2.31 Million Position in Charles River Laboratories International, Inc. $CRL - MarketBeat
Charles River Laboratories International (CRL) to Release Earnings on Wednesday - MarketBeat
Assessing Charles River Laboratories (CRL) Valuation After Recent Share Price Pullback - simplywall.st
Charles River Labs (CRL) Shares Decline Following Industry Peer Earnings Report - GuruFocus
Principal Financial Group Inc. Grows Position in Charles River Laboratories International, Inc. $CRL - MarketBeat
1 S&P 500 Stock with Competitive Advantages and 2 We Ignore - Finviz
Charles River and Synthace announce partnership for assay development - Drug Target Review
Charles River Laboratories International Insiders Up US$184k On US$1.25m Investment - 富途牛牛
Synthace & Charles River collaborate for robust, fast and cost-effective assays - SelectScience
Charles River Laboratories (CRL): Buy, Sell, or Hold Post Q3 Earnings? - Yahoo Finance
Canada Post Corp Registered Pension Plan Grows Position in Charles River Laboratories International, Inc. $CRL - MarketBeat
Is Charles River Laboratories stock underperforming the Dow? - MSN
Charles River Laboratories International (NYSE:CRL) Upgraded at Wall Street Zen - MarketBeat
Charles River shutters Maryland facility as activist investor pushes changes - The Business Journals
Oversold Conditions For Charles River Laboratories International (CRL) - Nasdaq
Charles River Laboratories International Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Pharmaceutical giant to close 20,000-square-foot facility, lay off 20 - The Business Journals
Charles River Laboratories International Inc (CRL) Shares Down 6 - GuruFocus
Charles River Laboratories to Close Maryland Cell Therapy Site, Cut 20 Jobs - Contract Pharma
Zacks Research Has Positive Outlook for CRL Q4 Earnings - MarketBeat
Charles River Laboratories International, Inc. $CRL Position Boosted by Van Berkom & Associates Inc. - MarketBeat
[Latest] Global Adeno Associated Virus Vector Manufacturing Market Size/Share Worth USD 9.87 Billion by 2035 at a 13.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
Shorts Report: Is Charles River Laboratories International Inc stock risky to hold nowJuly 2025 Highlights & Low Risk High Reward Ideas - baoquankhu1.vn
Bioburden Testing Market Generated Opportunities, Future - openPR.com
January M&A deals: Charles River Labs, Boston Scientific and ClearGov. - The Business Journals
Y Intercept Hong Kong Ltd Invests $1.18 Million in Charles River Laboratories International, Inc. $CRL - MarketBeat
RSI Check: What is the Moat Score of Charles River Laboratories International IncQuarterly Market Summary & Fast Gaining Stock Reports - baoquankhu1.vn
What Charles River Laboratories International (CRL)'s Royalty-Free AAV Plasmid Tie-Up Means For Shareholders - simplywall.st
Reducing animal testing 'an evolution and not a revolution' for life sci R&D, Charles River's incoming CEO says - Fierce Biotech
A Look At Charles River Laboratories (CRL) Valuation After Recent Share Price Momentum - Yahoo Finance
Universal Beteiligungs und Servicegesellschaft mbH Grows Stock Position in Charles River Laboratories International, Inc. $CRL - MarketBeat
Charles River Laboratories International, Inc. $CRL Shares Acquired by Cooke & Bieler LP - MarketBeat
What is the Moat Score of Charles River Laboratories International Inc.2025 AllTime Highs & Verified Stock Trade Ideas - mfd.ru
Charles River Labs Reshapes Gene Therapy Role While Legal Risks Linger - Sahm
Charles River Laboratories International (NYSE:CRL) Downgraded to Hold Rating by Wall Street Zen - MarketBeat
Charles River Laboratories International, Inc. (NYSE:CRL) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
77,056 Shares in Charles River Laboratories International, Inc. $CRL Bought by Rakuten Investment Management Inc. - MarketBeat
Charles River and Gazi University partner on gene therapy research By Investing.com - Investing.com Australia
Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call - Business Wire
Charles River, Gazi University Partner to Develop Advanced Therapies - Contract Pharma
Charles River (CRL) Expands Gene Therapy Collaboration with Gazi University - GuruFocus
Charles River and Gazi University partner on gene therapy research - Investing.com
Charles River Enters Manufacturing Collaboration with Gazi University - Business Wire
Charles River Laboratories Investigation Initiated: Kahn Swick & - GuruFocus
Charles River Laboratories Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc.CRL - PR Newswire
LaPlume of Charles River Labs sells $65k in stock By Investing.com - Investing.com Australia
Joseph Laplume Sells 400 Shares of Charles River Laboratories International (NYSE:CRL) Stock - MarketBeat
1.18%
자본화:
|
볼륨(24시간):